Zoter

Zoter may be available in the countries listed below.

Ingredient matches for Zoter

Acyclovir

Aciclovir is reported as an ingredient of Zoter in the following countries:

• Indonesia

International Drug Name Search

Cibadrex

Cibadrex may be available in the countries listed below.

Ingredient matches for Cibadrex

Benazepril

Benazepril hydrochloride (a derivative of Benazepril) is reported as an ingredient of Cibadrex in the following countries:

• Bahrain


• Bulgaria


• France


• Germany


• Ghana


• Greece


• Kenya


• Luxembourg


• Nigeria


• South Africa


• Spain


• Sudan


• Switzerland


• Tanzania


• Zimbabwe

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Cibadrex in the following countries:

• Bahrain


• Bulgaria


• France


• Germany


• Greece


• Luxembourg


• South Africa


• Spain


• Switzerland

International Drug Name Search

Salden

Salden may be available in the countries listed below.

Ingredient matches for Salden

Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salden in the following countries:

• Costa Rica


• Ecuador


• El Salvador


• Guatemala


• Honduras


• Nicaragua


• Panama

International Drug Name Search

Albalon

In the US, Albalon (naphazoline ophthalmic) is a member of the drug class ophthalmic antihistamines and decongestants and is used to treat Eye Dryness/Redness and Eye Redness/Itching.

US matches:

• Albalon

Ingredient matches for Albalon

Naphazoline

Naphazoline hydrochloride (a derivative of Naphazoline) is reported as an ingredient of Albalon in the following countries:

• Australia


• Bahrain


• Hong Kong


• Luxembourg


• Netherlands


• New Zealand


• Oman


• Thailand


• United States

International Drug Name Search

Fungafite

Fungafite may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Fungafite

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Fungafite in the following countries:

• Australia

International Drug Name Search

Ciprofibrate

UK matches:

• Ciprofibrate 100mg Tablets

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AB08

CAS registry number (Chemical Abstracts Service)

0052214-84-3

Chemical Formula

C13-H14-Cl2-O3

Molecular Weight

289

Therapeutic Category

Antilipemic agent, fibrate

Chemical Name

Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methyl-

Foreign Names

• Ciprofibratum (Latin)
• Ciprofibrat (German)
• Ciprofibrate (French)
• Ciprofibrato (Spanish)

Generic Names

• Ciprofibrate (OS: USAN, DCF, BAN)
• Win 35833 (IS: Winthrop)
• Ciprofibrate (PH: BP 2010, Ph. Eur. 6)
• Ciprofibratum (PH: Ph. Eur. 6)

Brand Names

• Cetaxin
  AC Farma, Peru



• Ciprofibrate Almus
  Almus, France



• Ciprofibrate Arrow
  Arrow, France



• Ciprofibrate Biogaran
  Biogaran, France



• Ciprofibrate Mylan
  Mylan, Belgium; Mylan, France



• Ciprofibrate Qualimed
  Qualimed, France



• Ciprofibrate Ratiopharm
  Ratiopharm, France



• Ciprofibrate RPG
  RPG, France



• Ciprofibrate Sandoz
  Sandoz, France



• Ciprofibrate Teva
  Teva Santé, France



• Ciprofibrate Winthrop
  Sanofi-Aventis, France



• Ciprofibrato
  Caferma, Peru



• Estabinol
  Panalab, Peru



• Estaprol
  Sanofi-Aventis, Argentina; Sanofi-Aventis, Chile



• Hiperlipen
  Sanofi-Aventis, Colombia; Sanofi-Aventis, Costa Rica; Sanofi-Aventis, Dominican Republic; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Guatemala; Sanofi-Aventis, Honduras; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Panama; Sanofi-Aventis, Peru; Sanofi-Aventis, El Salvador; Sanofi-Aventis, Venezuela



• Hyperlipen
  Sanofi-Aventis, Belgium; Sanofi-Aventis, Switzerland; Sanofi-Synthelabo, Luxembourg



• Lipanor
  Sanofi Aventis, Tunisia; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Estonia; Sanofi-Aventis, France; Sanofi-Aventis, Hungary; Sanofi-Aventis, Israel; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Latvia; Sanofi-Aventis, Poland; Sanofi-Aventis, Romania; Sanofi-Aventis, Serbia; Sanofi-Aventis, Slovakia; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal



• Modalim
  Sanofi-Aventis, Indonesia; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Singapore; Sanofi-Aventis, Vietnam; Winthrop Pharmaceuticals, United Kingdom



• Oroxadin
  Sanofi-Aventis, Brazil; Sanofi-Aventis, Mexico



• Savilen
  Sanofi-Synthelabo, Greece

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Ofirmev Injection

Pronunciation: a-SEET-a-MIN-oh-fen
Generic Name: Acetaminophen
Brand Name: Ofirmev

Ofirmev Injection is used for:

Managing mild to moderate pain and for reducing fever. It is also used to manage moderate to severe pain when used along with opioid pain medicines (eg, oxycodone).

Ofirmev Injection is an analgesic and antipyretic (lowers fever). Exactly how it works is not known but it is thought to work by lowering a chemical in the brain that stimulates pain nerves and the heat-regulating center in the brain.

Do NOT use Ofirmev Injection if:

• you are allergic to any ingredient in Ofirmev Injection


• you have severe liver problems

Contact your doctor or health care provider right away if any of these apply to you.

Before using Ofirmev Injection:

Some medical conditions may interact with Ofirmev Injection. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of alcohol abuse or you drink more than 3 alcohol-containing drinks every day


• if you have liver problems (eg, hepatitis), poor nutrition, low blood volume (eg, caused by dehydration or blood loss), or kidney problems

Some MEDICINES MAY INTERACT with Ofirmev Injection. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anticoagulants (eg, warfarin) because the risk of their side effects, including bleeding, may be increased by Ofirmev Injection


• Isoniazid or other medicines that may harm the liver (eg, methotrexate, ketoconazole, certain medicines for HIV infection) because the risk of liver problems may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver

This may not be a complete list of all interactions that may occur. Ask your health care provider if Ofirmev Injection may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Ofirmev Injection:

Use Ofirmev Injection as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Ofirmev Injection is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Ofirmev Injection at home, a health care provider will teach you how to use it. Be sure you understand how to use Ofirmev Injection. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.


• Do not mix other medicines (especially chlorpromazine or diazepam) in the same container or IV line as Ofirmev Injection. Contact your health care provider if you have any questions about how to give Ofirmev Injection with other medicines.


• Do not use Ofirmev Injection if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• Use Ofirmev Injection within 6 hours after opening.


• If you miss a dose of Ofirmev Injection and you are using it regularly, use it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Ofirmev Injection.

Important safety information:

• Ofirmev Injection has acetaminophen in it. Before you start any new medicine, check the label to see if it has acetaminophen in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Ofirmev Injection may harm your liver. Your risk may be greater if you drink alcohol while you are using Ofirmev Injection or if you use Ofirmev Injection in high doses. Talk to your doctor before you use Ofirmev Injection or other fever reducers if you drink more than 3 drinks with alcohol per day. Do NOT use more than the recommended dose without checking with your doctor.


• Ofirmev Injection should be used with extreme caution in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ofirmev Injection while you are pregnant. Ofirmev Injection is found in breast milk. If you are or will be breast-feeding while you use Ofirmev Injection, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Ofirmev Injection:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation, headache, mild nausea or vomiting, or trouble sleeping.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue); agitation or anxiety; dark urine or pale stools; fainting; fast heartbeat; muscle pain, spasms, weakness, or cramping; pain, redness, or swelling at the injection site; persistent spasm of the jaw muscles; severe or persistent headache or dizziness; shortness of breath; stomach pain; swelling of the hands, ankles, or feet; unusual tiredness or weakness; wheezing; yellowing of the skin or eyes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Ofirmev side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; dark urine; decreased urination; excessive sweating; extreme fatigue; nausea and vomiting; pale stools; stomach pain; unusual bruising or bleeding; yellowing of the skin or eyes.

Proper storage of Ofirmev Injection:

Ofirmev Injection is usually handled and stored by a health care provider. If you are using Ofirmev Injection at home, store Ofirmev Injection as directed by your pharmacist or health care provider. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Ofirmev Injection out of the reach of children and away from pets.

General information:

• If you have any questions about Ofirmev Injection, please talk with your doctor, pharmacist, or other health care provider.


• Ofirmev Injection is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Ofirmev Injection. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Ofirmev resources

• Ofirmev Side Effects (in more detail)
• Ofirmev Use in Pregnancy & Breastfeeding
• Ofirmev Drug Interactions
• Ofirmev Support Group
• 0 Reviews for Ofirmev - Add your own review/rating

Compare Ofirmev with other medications

• Fever
• Pain

Risperidona Sandoz

Risperidona Sandoz may be available in the countries listed below.

Ingredient matches for Risperidona Sandoz

Risperidone

Risperidone is reported as an ingredient of Risperidona Sandoz in the following countries:

• Portugal


• Spain

International Drug Name Search

Méphénésine

Méphénésine may be available in the countries listed below.

Ingredient matches for Méphénésine

Mephenesin

Méphénésine (DCF) is also known as Mephenesin (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.